Sanofi’s Commitment to Hematology
ABOUT US
2020-01-27LL

Perseverance in Rare Diseases

<br><br>At Sanofi, we want to create a workplace where differences are leveraged to empower the lives of our employees, patients and customers



Voices from the lab : Nadine Biesemann

Voices from the Lab

Meet the men and women behind the lab coats and microscopes, who are building this future, and discover the science that is helping them do it

5 things you need to know - Risk of heart Disease

KiDS Program Aims to Keep Children with Diabetes in School

 
Science and Innovation Image
SCIENCE & INNOVATION

Sanofi Scientists Aim to Stop Abnormal Immune Response in Rare Blood Disorders

Real-World Evidence Turns Experience into Knowledge

Next Generation Approaches to Pioneer Breakthrough Therapies




  • Camera
    Press releases
    2020-01-28MMMM DD YYYY
    Sanofi : FDA accepts for priority review Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis

This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.

Click here for more information on cookies
OK